Advertisement
Research Article Free access | 10.1172/JCI112605
Find articles by Salier, J. in: JCI | PubMed | Google Scholar
Find articles by Sesboüé, R. in: JCI | PubMed | Google Scholar
Find articles by Martin-Mondière, C. in: JCI | PubMed | Google Scholar
Find articles by Daveau, M. in: JCI | PubMed | Google Scholar
Find articles by Cesaro, P. in: JCI | PubMed | Google Scholar
Find articles by Cavelier, B. in: JCI | PubMed | Google Scholar
Find articles by Coquerel, A. in: JCI | PubMed | Google Scholar
Find articles by Legrand, L. in: JCI | PubMed | Google Scholar
Find articles by Goust, J. in: JCI | PubMed | Google Scholar
Find articles by Degos, J. in: JCI | PubMed | Google Scholar
Published August 1, 1986 - More info
In some Caucasian populations, multiple sclerosis (MS) susceptibility has been independently related to given alleles of HLA or Gm systems that respectively code for major histocompatibility complex class I and II antigens or immunoglobulin G heavy chains. Whether given combinations of alleles at both series of loci simultaneously influence MS susceptibility and/or severity was investigated by comparing 147 French MS patients and 226 geographically-matched healthy controls. The G2m(-23)/HLA-B35 phenotype and G1m(-1)/HLA-B7(-)/HLA-DR2 phenotype were respectively associated with significant protection against (relative risk = 0.05) and susceptibility to (relative risk = 4.3) MS. When considering MS severity, the presence of HLA-B7 antigen correlated with a more severe disease in Gm1/Gm3 heterozygous patients, but not in Gm3/Gm3 homozygous patients. Conversely, an HLA-B12-associated milder disease was restricted to Gm3/Gm3 homozygotes. These results demonstrate the combined influence on MS of genetic loci that are unlinked but immune response-associated. Combined Gm and HLA typing is very likely able to serve as a prognostic indicator in this disease.